During the last session, Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s traded shares were 56079.0, with the beta value of the company hitting 0.62. At the end of
Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s traded shares stood at 0.67 million during the last session, with the company’s beta value hitting -0.99. At the close of
In last trading session, Telomir Pharmaceuticals Inc (NASDAQ:TELO) saw 0.31 million shares changing hands with its beta currently measuring -1.99. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
